you sort of missed the point, methinks. Don't you think it's a little strange, implausible even, that the directors of Bioprospect, noted for their brilliance in developing insecticides and mines, have uncovered an aussie battler psychiatrist who has a simple yet groundbreaking test for mental illness that nobody else has ever thought of? Pfizer must be kicking itself on missing out on this opportunity. Good luck on this investment decision.
BPO Price at posting:
0.4¢ Sentiment: Sell Disclosure: Not Held